The Hologic Brevera® system represents a major leap forward in breast biopsy procedures, significantly enhancing accuracy, reducing procedure times, and improving patient comfort across all HSE-funded breast centres in Ireland. This system integrates real-time imaging with tissue acquisition, allowing clinicians to assess tissue quality in seconds, which minimizes patient wait times and enhances overall efficiency.

This nomination underscores our commitment to healthcare innovation and patient-centered solutions. HSL is proud to be recognised for our contributions to the future of diagnostic care in Ireland, and we look forward to continuing our work to bring transformative health technology to the communities we serve.

The post HSL Shortlisted for Health Tech Ireland Award for Transformative Impact in Diagnostics appeared first on Hospital Services Limited UK.